Preveon
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Updates are provided for new anti-HIV drugs currently in development. ABT-378, Tipranavir, and DMP-450 are among the new…
The FDA's Antiviral Drugs Advisory Committee voted against approval of adefovir dipivoxil (Preveon) for treating HIV. Although…
Data on Gilead's anti-HIV drug, adefovir dipivoxil (Preveon), were presented at the 12th International Conference on Antiviral…
More antiretroviral drugs are becoming available, increasing potential treatment regimens but also increasing the complexity of…
Gilead Sciences, makers of adefovir dipivoxil (preveon), has observed varying levels of kidney-related abnormalities in…
The trial program for adefovir dipivoxil (preveon), an anti-HIV drug, has been expanded to include individuals whose current…
Gilead Sciences has seen beneficial results from two trials of adefovir dipivoxil (Preveon) in the treatment of HIV. An…
Gilead Sciences is removing the CD-4 and viral load requirements for people to enter its expanded access program for adefovir…
Gilead Sciences has modified its expanded access program for its experimental antiviral adefovir dipivoxil (Preveon). Entry…
Adefovir dipivoxil (Preveon), a nucleotide analog and a prodrug of PMEA, has been approved for a limited expanded access…